Fig. 2From: Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseasesThe CSMS in different years. a The CSMS were no differences in the patients with LRs and without LRs (p>0.05); b The CSMS were no differences in the patients with SRs and without SRs (p>0.05)Back to article page